AP
IMMX icon

Aspect Partners’s Immix Biopharma IMMX Stock Holding History

Aspect Partners’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907 Buy
88
+79
+878% +$733 ﹤0.01% 584
2026
Q1 		$82 Buy
+9
New +$66 ﹤0.01% 702

Other funds holding IMMX

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Aspect Partners's IMMX Position: Q2 2026 in Review

Aspect Partners increased its Immix Biopharma (IMMX) stake by 878% in Q2 2026, buying an estimated $733 and bringing the position to 88 shares worth $907. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Aspect Partners first reported a position in IMMX in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Aspect Partners held 88 shares of Immix Biopharma worth $907 as of Q2 2026.
  • Aspect Partners bought 79 Immix Biopharma shares in Q2 2026, an estimated $733.
  • Immix Biopharma made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #584 holding.
  • Aspect Partners first reported a position in Immix Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.